Analysis Note

Clotting activity is determined by comparison to a standard curve produced using normal pooled human plasma

single band by SDS-PAGE

General description

Native coagulation factor X from human plasma. In the coagulation cascade, Factor X is converted to Factor Xa, the enzyme that converts prothrombin to thrombin by either the extrinsic or intrinsic pathway. Sold on the basis of units where one unit equals the amount of factor X in 1 ml pooled human plasma (100 units = 0.8 mg). In the coagulation cascade, Factor X is converted to Factor Xa, the enzyme which converts prothrombin to thrombin by either the extrinsic or intrinsic pathway.

Native coagulation factor X from human plasma. In the coagulation cascade, Factor X is converted to Factor Xa, the enzyme that converts prothrombin to thrombin by either the extrinsic or intrinsic pathway. Sold on the basis of units where one unit equals the amount of Factor X in 1 ml pooled human plasma (100 units = 0.8 mg Factor X).

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Packaging

100 u in Plastic ampoule

Please refer to vial label for lot-specific concentration.

Physical form

In 100 mM NaCl, 20 mM Tris-HCl, 1 mM benzamidine, pH 7.4.

Preparation Note

Prepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

Reconstitution

Following initial thaw, aliquot and freeze (-70°C).

Warning

Toxicity: Standard Handling (A)